Clinical Trials on The Patients Suffered With Sellar Diseases in Argentina
Total 6 results
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Novartis PharmaceuticalsCompletedObese Patients With Non-alcoholic Steatohepatitis (NASH)Netherlands, Taiwan, Thailand, United States, Israel, Argentina, Russian Federation, Canada
-
University of LouisvilleBiocompatibles UK LtdCompletedColon Cancer With Metastases to the LiverUnited States, Argentina
-
NYU Langone HealthRecruitingParkinson Disease | Multiple System Atrophy | Neurogenic Orthostatic Hypotension | REM Sleep Behavior Disorder | Pure Autonomic Failure | Dementia With Lewy Bodies | Patients With Synucleinopathies | Shy-Drager DiseaseKorea, Republic of, United States, Argentina, Spain
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more